Heparan sulfates in the lung: Structure, diversity, and role in pulmonary emphysema

Anatomical Record

Volumn 293, Issue 6, 2010, Pages 955-967

  Smits, Nicole C ^a,b   Shworak, Nicholas W ^b   Dekhuijzen, P N Richard ^c   Van Kuppevelt, Toin H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Emphysema; Extracellular matrix; Heparan sulfates; Lung; Patho(physiology)

Indexed keywords

AGRIN; BONE MORPHOGENETIC PROTEIN 4; CHONDROITIN SULFATE; COLLAGEN; COLLAGEN TYPE 4; DERMATAN SULFATE; ELASTIN; ENDOSTATIN; ENTACTIN; FIBRILLIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GLYCOSAMINOGLYCAN; GLYCOSYLTRANSFERASE; HEPARAN SULFATE; HEXOSAMINE; HEXURONIC ACID; LAMININ; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SYNDECAN 1; SYNDECAN 4; WNT5A PROTEIN; XANTHINE OXIDASE;

BASEMENT MEMBRANE; BIOSYNTHESIS; BLOOD VESSEL; BRONCHIOLE; CARTILAGE MATRIX; CELL SURFACE; CHRONIC INFLAMMATION; CONNECTIVE TISSUE; EOSINOPHIL; EPIDERMIS; EXTRACELLULAR MATRIX; EYE MALFORMATION; FEMALE FERTILITY; GENE MUTATION; GOLGI COMPLEX; HISTOCHEMISTRY; HOMOZYGOTE; IN VITRO STUDY; KIDNEY; LUNG; LUNG ALVEOLITIS; LUNG ALVEOLUS MACROPHAGE; LUNG DEVELOPMENT; LUNG EMPHYSEMA; MALE FERTILITY; MAST CELL; MESODERM; MORPHOLOGY; NEUROMUSCULAR SYNAPSE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RESPIRATORY TRACT INFECTION; RETINA; REVIEW; SKELETON; SMOOTH MUSCLE FIBER; SYSTEMATIC REVIEW; TISSUE REPAIR; TUMOR GROWTH; URINALYSIS;

ANIMALS; HEPARITIN SULFATE; HUMANS; LUNG; PULMONARY ALVEOLI; PULMONARY EMPHYSEMA; RESPIRATORY MUCOSA;

EID: 77953168114     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20895     Document Type: Review

References (124)

1. Adachi T, Fukushima T, Usami Y, Hirano K. 1993. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289 (Pt 2):523-527. (Pubitemid 23042063)
2. Aikawa J, Esko JD. 1999. Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family. J Biol Chem 274:2690-2695. (Pubitemid 29075348)
3. Aikawa J, Grobe K, Tsujimoto M, Esko JD. 2001. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. J Biol Chem 276:5876-5882. (Pubitemid 37385743)
4. Al Jamal R, Roughley PJ, Ludwig MS. 2001. Effect of glycosaminoglycan degradation on lung tissue viscoelasticity. Am J Physiol Lung Cell Mol Physiol 280:L306-L315. (Pubitemid 32473223)
5. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. 1992. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365-393. (Pubitemid 23001002)
6. Bullock SL, Fletcher JM, Beddington RS, Wilson VA. 1998. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev 12:1894-1906.
7. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J. 1999. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson- Golabi-Behmel syndrome. J Cell Biol 146:255-264. (Pubitemid 29349979)
8. Cantor JO, Turino GM. 2004. Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema? Chest 125:288-292.
9. Carey DJ. 1997. Syndecans: multifunctional cell-surface co-receptors. Biochem J 327 (Pt 1):1-16.
10. Cizmeci-Smith G, Langan E, Youkey J, Showalter LJ, Carey DJ. 1997. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:172-180. (Pubitemid 27057340)
11. Cizmeci-Smith G, Stahl RC, Showalter LJ, Carey DJ. 1993. Differential expression of transmembrane proteoglycans in vascular smooth muscle cells. J Biol Chem 268:18740-18747. (Pubitemid 23273818)
12. Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R. 1999. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109-1122.
13. Costell M, Mann K, Yamada Y, Timpl R. 1997. Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides. Eur J Biochem 243:115-121. (Pubitemid 27060392)
14. Couchman JR, Woods A. 1996. Syndecans, signaling, and cell adhesion. J Cell Biochem 61:578-584.
15. Crawford BE, Olson SK, Esko JD, Pinhal MA. 2001. Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase. J Biol Chem 276:21538-21543. (Pubitemid 37413151)
16. Danielsen CC. 1982. Mechanical properties of reconstituted collagen fibrils. Influence of a glycosaminoglycan: dermatan sulfate. Connect Tissue Res 9:219-225.
17. David G. 1993. Integral membrane heparan sulfate proteoglycans. Faseb J 7:1023-1030. (Pubitemid 23243444)
18. Deepa SS, Yamada S, Zako M, Goldberger O, Sugahara K. 2004. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J Biol Chem 279:37368-37376. (Pubitemid 39195445)
19. Dempsey LA, Brunn GJ, Platt JL. 2000. Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 25:349-351.
20. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP, Jr., 2001. Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293:1663-1666.
21. Dong S, Cole GJ, Halfter W. 2003. Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites. J Biol Chem 278:1700-1707. (Pubitemid 36801403)
22. Elenius V, Gotte M, Reizes O, Elenius K, Bernfield M. 2004. Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1. J Biol Chem 279:41928-41935. (Pubitemid 39313642)
23. Eriksson I, Sandback D, Ek B, Lindahl U, Kjellen L. 1994. cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase, an enzyme involved in the biosynthesis of heparin. J Biol Chem 269:10438-10443. (Pubitemid 24198240)
24. Eriksson S. 1991. The potential role of elastase inhibitors in emphysema treatment. Eur Respir J 4:1041-1043.
25. Esko JD, Selleck SB. 2002. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435-471.
26. Fan G, Xiao L, Cheng L, Wang X, Sun B, Hu G. 2000. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett 467:7-11. (Pubitemid 30069532)
27. Ferrara TB, Fox RB. 1992. Effects of oxygen toxicity on cuprolinic blue-stained proteoglycans in alveolar basement membranes. Am J Respir Cell Mol Biol 6:219-224.
28. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. 1995. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152:1666-1672. (Pubitemid 3002087)
29. Forsberg E, Kjellen L. 2001. Heparan sulfate: lessons from knockout mice. J Clin Invest 108:175-180. (Pubitemid 32656239)
30. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullberg M, Eriksson I, Ledin J, Hellman L, Kjellen L. 1999. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400:773-776. (Pubitemid 29399539)
31. Frevert CW, Sannes PL. 2005. Matrix proteoglycans as effector molecules for epithelial cell function. Eur Respir Rev 14:137-144.
32. Gadek JE, Pacht ER. 1990. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung 168 Suppl:552-564.
33. Groffen AJ, Buskens CA, van Kuppevelt TH, Veerkamp JH, Monnens LA, van den Heuvel LP. 1998. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 254:123-128.
34. Habuchi H, Nagai N, Sugaya N, Atsumi F, Stevens RL, Kimata K. 2007. Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation and late embryonic lethality. J Biol Chem 282:15578-15588. (Pubitemid 47093285)
35. Halfter W, Dong S, Schurer B, Cole GJ. 1998. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 273:25404-25412. (Pubitemid 28443308)
36. Hashimoto Y, Orellana A, Gil G, Hirschberg CB. 1992. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J Biol Chem 267:15744-15750.
37. Hinek A, Mecham RP, Keeley F, Rabinovitch M. 1991. Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J Clin Invest 88:2083-2094.
38. Humphries DE, Sullivan BM, Aleixo MD, Stow JL. 1997. Localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase to the trans-Golgi network. Biochem J 325 (Pt 2): 351-357.
39. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, Sharpe AH, Stevens RL. 1999. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400:769-772. (Pubitemid 29399538)
40. Izvolsky KI, Lu J, Martin G, Albrecht KH, Cardoso WV. 2008. Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis. Genesis 46:8-18. (Pubitemid 351413583)
41. Izvolsky KI, Shoykhet D, Yang Y, Yu Q, Nugent MA, Cardoso WV. 2003. Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol 258:185-200. (Pubitemid 36627665)
42. Juul SE, Wight TN, Hascall VC. 1991.Proteoglycans. In:Crystal RC,West JB, editors. The lung, scientific foundations. Vol I. NY: Raven Press. p 413-420.
43. Karlinsky J, Fredette J, Davidovits G, Catanese A, Snider R, Faris B, Snider GL, Franzblau C. 1983. The balance of lung connective tissue elements in elastase-induced emphysema. J Lab Clin Med 102:151-162. (Pubitemid 13029254)
44. Karlinsky JB. 1982. Glycosaminoglycans in emphysematous and fibrotic hamster lungs. Am Rev Respir Dis 125:85-88.
45. Katoh S, Matsubara Y, Taniguchi H, Fukushima K, Mukae H, Kadota J, Matsukura S, Kohno S. 2001. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis. Clin Exp Immunol 126:545-550. (Pubitemid 34008731)
46. Katoh S, Matsumoto N, Kawakita K, Tominaga A, Kincade PW, Matsukura S. 2003. A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia. J Clin Invest 111:1563-1570. (Pubitemid 38063289)
47. Kojima T. 2000. Molecular biology of ryudocan, an endothelial heparan sulfate proteoglycan. Semin Thromb Hemost 26:67-73.
48. Konno K, Arai H, Motomiya M, Nagai H, Ito M, Sato H, Satoh K. 1982. A biochemical study on glycosaminoglycans (mucopolysaccharides) in emphysematous and in aged lungs. Am Rev Respir Dis 126:797-801. (Pubitemid 13241059)
49. Kreuger J, Spillmann D, Li JP, Lindahl U. 2006. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 174:323-327. (Pubitemid 44156762)
50. Kusche-Gullberg M, Eriksson I, Pikas DS, Kjellen L. 1998. Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N- sulfotransferase genes. J Biol Chem 273:11902-11907. (Pubitemid 28272098)
51. Lafuma C, Frisdal E, Harf A, Robert L, Hornebeck W. 1991. Prevention of leucocyte elastase-induced emphysema in mice by heparin fragments. Eur Respir J 4:1004-1009.
52. Lafuma C, Moczar M, Lange F, Robert L. 1985. Biosynthesis of hyaluronic acid, heparan sulfate and structural glycoproteins in hamster lung explants during elastase induced emphysema. Connect Tissue Res 13:169-179. (Pubitemid 15161415)
53. Langford JK, Stanley MJ, Cao D, Sanderson RD. 1998. Multiple heparan sulfate chains are required for optimal syndecan-1 function. J Biol Chem 273:29965-29971. (Pubitemid 28510014)
54. Laros CD, Kuyper CM, Janssen HM. 1972. The chemical composition of fresh human lung parenchyma. An approach to the pathogenesis of lung emphysema. Respiration 29:458-467.
55. Lensen JF, Wijnhoven TJ, Kuik LH, Versteeg EM, Hafmans T, Rops AL, Pavao MS, van der Vlag J, van den Heuvel LP, Berden JH, van Kuppevelt TH. 2006. Selection and characterization of a unique phage display-derived antibody against dermatan sulfate. Matrix Biol 25:457-461. (Pubitemid 44515191)
56. Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U. 2001. Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem 276:20069-20077. (Pubitemid 37411076)
57. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, Zhang X, Lindahl U. 2003. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 278:28363-28366. (Pubitemid 36935735)
58. Li Q, Olsen BR. 2004. Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am J Pathol 165:415-424. (Pubitemid 38971372)
59. Li Q, Park PW, Wilson CL, Parks WC. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635-646. (Pubitemid 35441246)
60. Li ZY, Hirayoshi K, Suzuki Y. 2000. Expression of N-deacetylase/ sulfotransferase and 3-O-sulfotransferase in rat alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 279:L292-L301.
61. Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, Matzuk MM. 2000. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224:299-311. (Pubitemid 30661012)
62. Linker A, Hovingh P. 1973. The heparitin sulfates (heparan sulfates). Carbohydr Res 29:41-62.
63. Linker A, Hovingh P. 1975. Structural studies of heparitin sulfates. Biochim Biophys Acta 385:324-333.
64. Lopez-Casillas F, Riquelme C, Perez-Kato Y, Ponce-Castaneda MV, Osses N, Esparza-Lopez J, Gonzalez-Nunez G, Cabello-Verrugio C, Mendoza V, Troncoso V, Brandan E. 2003. Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. J Biol Chem 278:382-390. (Pubitemid 36043587)
65. Lopez-Casillas F, Wrana JL, Massague J. 1993. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73:1435-1444. (Pubitemid 23201155)
66. Lum DH, Tan J, Rosen SD, Werb Z. 2007. Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol Cell Biol 27:678-688. (Pubitemid 46080133)
67. Marneros AG, Olsen BR. 2005. Physiological role of collagen XVIII and endostatin. Faseb J 19:716-728. (Pubitemid 40617376)
68. McGowan SE, Liu R, Harvey CS. 1993. Effects of heparin and other glycosaminoglycans on elastin production by cultured neonatal rat lung fibroblasts. Arch Biochem Biophys 302:322-331. (Pubitemid 23212677)
69. Mochizuki H, Yoshida K, Gotoh M, Sugioka S, Kikuchi N, Kwon YD, Tawada A, Maeyama K, Inaba N, Hiruma T, Kimata K, Narimatsu H. 2003. Characterization of a heparan sulfate 3-O-sulfotransferase- 5, an enzyme synthesizing a tetrasulfated disaccharide. J Biol Chem 278:26780-26787. (Pubitemid 36876826)
70. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD. 2002. Cloning and characterization of two extracellular heparin- degrading endosulfatases in mice and humans. J Biol Chem 277:49175-49185. (Pubitemid 36014346)
71. Nagamine S, Koike S, Keino-Masu K, Masu M. 2005. Expression of a heparan sulfate remodeling enzyme, heparan sulfate 6-O-endosulfatase sulfatase FP2, in the rat nervous system. Brain Res Dev Brain Res 159:135-143. (Pubitemid 41338323)
72. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, Tashiro K, Ross J, Jr., Honjo T, Chien KR. 2002. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415:171-175.
73. Negrini D, Passi A, De Luca,G. 2003. Matrix proteoglycans in development of pulmonary edema. Garg HG, Roughly PJ, Hales CA, eds. In: Lung biology in health and disease. New York: Marcel Dekker, Inc.
74. Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, Hamida CB, Hammouda H, Cruaud C, White PS, Samson D, Urtizberea JA, Lehmann-Horn F, Weissenbach J, Hentati F, Fontaine B. 2000. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 26:480-483.
75. Ohto T, Uchida H, Yamazaki H, Keino-Masu K, Matsui A, Masu M. 2002. Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid plexus and cartilage. Genes Cells 7:173-185. (Pubitemid 34213362)
76. Orellana A, Hirschberg CB, Wei Z, Swiedler SJ, Ishihara M. 1994. Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. J Biol Chem 269:2270-2276. (Pubitemid 24978473)
77. Pall T, Gad A, Kasak L, Drews M, Stromblad S, Kogerman P. 2004. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding. Oncogene 23:7874-7881. (Pubitemid 39457037)
78. Pallerla SR, Lawrence R, Lewejohann L, Pan Y, Fischer T, Schlomann U, Zhang X, Esko JD, Grobe K. 2008. Altered heparan sulfate structure in mice with deleted NDST3 gene function. J Biol Chem 283:16885-16894.
79. Petitou M, van Boeckel CA. 2004. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Angew Chem Int Ed Engl 43:3118-3133.
80. Raats CJ, Bakker MA, van den Born J, Berden JH. 1997. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 272:26734-26741.
81. Radhakrishnamurthy B, Jeansonne NE, Berenson GS. 1984. Heterogeneity of heparan sulfate chains in a proteoglycan from bovine lung. Biochim Biophys Acta 802:314-320. (Pubitemid 15214121)
82. Radhakrishnamurthy B, Jeansonne NE, Smart FW, Berenson GS. 1985. Proteoglycans from lungs of rabbits treated with pronase and cadmium chloride. Am Rev Respir Dis 131:855-861. (Pubitemid 15065915)
83. Rao NV, Kennedy TP, Rao G, Ky N, Hoidal JR. 1990. Sulfated polysaccharides prevent human leukocyte elastase-induced acute lung injury and emphysema in hamsters. Am Rev Respir Dis 142:407-412. (Pubitemid 20235954)
84. Rapraeger AC, Ott VL. 1998. Molecular interactions of the syndecan core proteins. Curr Opin Cell Biol 10:620-628.
85. Redini F, Lafuma C, Hornebeck W, Choay J, Robert L. 1988. Influence of heparin fragments on the biological activities of elastase(s) and alpha 1 proteinase inhibitor. Biochem Pharmacol 37: 4257-4261. (Pubitemid 18265745)
86. Repine JE, Bast A, Lankhorst I. 1997. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156:341-357.
87. Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, Eriksson I, Olofsson AM, Kjellen L, Forsberg E. 2000. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem 275: 25926-25930.
88. Roberts CR, Wight TN, Gascall VC. 1997.Proteoglycans. In:Crystal RG,West JB, editors. The lung: scientific foundations. 2nd ed. Philadelphia: Lippincott, Raven Publishers, Philadelphia. p 757-767.
89. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. 1997. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 99:2062-2070.
90. Sannes PL. 1984. Differences in basement membrane-associated microdomains of type I and type II pneumocytes in the rat and rabbit lung. J Histochem Cytochem 32:827-833.
91. Sannes PL, Burch KK, Khosla J. 1992. Immunohistochemical localization of epidermal growth factor and acidic and basic fibroblast growth factors in postnatal developing and adult rat lungs. Am J Respir Cell Mol Biol 7:230-237.
92. Sannes PL, Khosla J, Cheng PW. 1996. Sulfation of extracellular matrices modifies responses of alveolar type II cells to fibroblast growth factors. Am J Physiol 271:L688-L697. (Pubitemid 26405922)
93. Sannes PL, Khosla J, Li CM, Pagan I. 1998. Sulfation of extracellular matrices modifies growth factor effects on type II cells on laminin substrata. Am J Physiol 275:L701-L708. (Pubitemid 28491852)
94. Shah L, Walter KL, Borczuk AC, Kawut SM, Sonett JR, Gorenstein LA, Ginsburg ME, Steinglass KM, Powell CA. 2004. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Cancer 101:1632-1638. (Pubitemid 39318911)
95. Shriver Z, Raman R, Venkataraman G, Drummond K, Turnbull J, Toida T, Linhardt R, Biemann K, Sasisekharan R. 2000. Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site. Proc Natl Acad Sci USA 97:10359-10364.
96. Shworak NW, HajMohammadi S, de Agostini AI, Rosenberg RD. 2002. Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes. Glycoconj J 19:355-361. (Pubitemid 37174566)
97. Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M, Copeland NG, Jenkins NA, Rosenberg RD. 1999. Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci. J Biol Chem 274:5170-5184. (Pubitemid 129501540)
98. Smetsers TF, van de Westerlo EM, Ten Dam GB, Overes IM, Schalkwijk J, van Muijen GN, van Kuppevelt TH. 2004. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol 122:707-716. (Pubitemid 38471340)
99. Smits NC, Lensen JFM, Wijnhoven TJM, Ten Dam GTD, Jenniskens GJ, van Kuppevelt TH. 2006. Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Methods Enzymol 416:61-87.
100. Smits NC, Robbesom AA, Versteeg EM, Van De Westerlo EM, Dekhuijzen PN, Van Kuppevelt TH. 2004. Heterogeneity of heparan sulfates in human lung. Am J Respir Cell Mol Biol 30:166-173.
101. Snider GL. 1992. Emphysema: the first two centuries - and beyond. A historical overview, with suggestions for future research: Part 2. Am Rev Respir Dis 146:1615-1622.
102. Stickens D, Zak BM, Rougier N, Esko JD, Werb Z. 2005. Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132:5055-5068. (Pubitemid 41764016)
103. Stone PJ, McMahon MP, Morris SM, Calore JD, Franzblau C. 1987. Elastin in a neonatal rat smooth muscle cell culture has greatly decreased susceptibility to proteolysis by human neutrophil elastase. An in vitro model of elastolytic injury. In Vitro Cell Dev Biol 23:663-676.
104. Sugahara K, Kitagawa H. 2000. Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol 10:518-527.
105. Teriete P, Banerji S, Noble M, Blundell CD, Wright AJ, Pickford AR, Lowe E, Mahoney DJ, Tammi MI, Kahmann JD, Campbell ID, Day AJ, Jackson DG. 2004. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol Cell 13:483-496. (Pubitemid 38299377)
106. TheAmerican Thoracic Society. 1998. Update: future directions for research on diseases of the lung. Am J Respir Crit Care Med 158:320-334. (Pubitemid 28337198)
107. Tibell LA, Sethson I, Buevich AV. 1997. Characterization of the heparin- binding domain of human extracellular superoxide dismutase. Biochim Biophys Acta 1340:21-32. (Pubitemid 27274047)
108. Timens W, Coers W, Van Straaten JFM, Postma DS. 1997. Extracellular matrix and inflammation: a role forfibroblast-mediated defective tissue repair in the pathogenesis of emphysema? Eur Respir Rev 7:119-123.
109. Turnbull JE, Hopwood JJ, Gallagher JT. 1999. A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc Natl Acad Sci USA 96:2698-2703.
110. van de Lest CH, Versteeg EM, Veerkamp JH, Berden JH, van den Born J, Heunks L, Lammers JW, van Herwaarden CL, Dekhuijzen PN, van Kuppevelt TH. 1996. Altered composition of urinary heparan sulfate in patients with COPD. Am J Respir Crit Care Med 154:952-958. (Pubitemid 126679530)
111. van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH. 1995. Digestion of proteoglycans in porcine pancreatic elastase-induced emphysema in rats. Eur Respir J 8:238-245.
112. van De Westerlo EM, Smetsers TF, Dennissen MA, Linhardt RJ, Veerkamp JH, van Muijen GN, van Kuppevelt TH. 2002. Human single chain antibodies against heparin: selection, characterization, and effect on coagulation. Blood 99:2427-2433.
113. van Kuppevelt TH, Cremers FP, Domen JG, Kuyper CM. 1984. Staining of proteoglycans in mouse lung alveoli. II. Characterization of the Cuprolinic blue-positive, anionic sites. Histochem J 16:671-686.
114. van Kuppevelt TH, Cremers FP, Domen JG, van Beuningen HM, van den Brule AJ, Kuyper CM. 1985. Ultrastructural localization and characterization of proteoglycans in human lung alveoli. Eur J Cell Biol 36:74-80. (Pubitemid 15165580)
115. van Kuppevelt TH, van de Lest CH, Versteeg EM, Dekhuijzen PN, Veerkamp JH. 1997. Induction of emphysematous lesions in rat lung by beta-D-xyloside, an inhibitor of proteoglycan synthesis. Am J Respir Cell Mol Biol 16:75-84.
116. van Kuppevelt TH, Veerkamp JH. 1994. Application of cationic probes for the ultrastructural localization of proteoglycans in basement membranes. Microsc Res Tech 28:125-140.
117. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman HF, Timens W, Postma DS. 1999. Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 12:697-705. (Pubitemid 29354883)
118. Vilar RE, Ghael D, Li M, Bhagat DD, Arrigo LM, Cowman MK, Dweck HS, Rosenfeld L. 1997. Nitric oxide degradation of heparin and heparan sulphate. Biochem J 324 (Pt 2):473-479. (Pubitemid 27267990)
119. Vogel KG, Paulsson M, Heinegard D. 1984. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 223:587-597. (Pubitemid 15209051)
120. Walsh RL, Dillon TJ, Scicchitano R, McLennan G. 1991. Heparin and heparan sulphate are inhibitors of human leucocyte elastase. Clin Sci (Lond) 81:341-346.
121. Wang Y, Sakamoto K, Khosla J, Sannes PL. 2002. Detection of chondroitin sulfates and decorin in developing fetal and neonatal rat lung. Am J Physiol Lung Cell Mol Physiol 282:L484-L490. (Pubitemid 34654651)
122. Webb LM, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 90:7158-7162. (Pubitemid 23222408)
123. Werb Z, Banda MJ, Jones PA. 1980. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J Exp Med 152:1340-1357. (Pubitemid 11241633)
124. Yu Q, Toole BP. 1996. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44. J Biol Chem 271:20603-20607. (Pubitemid 26281838)